Urgent.News

What's breaking now, across thousands of outlets.

AI

Spotify to label AI generated artist profiles

Spotify will introduce “AI Persona” badges on some artist profiles from mid-September. The move aims to give listeners more information about whether an artist represents a real person. Spotify said some users had raised concerns about human-looking profiles created through artificial intelligence. The company wants to improve transparency as AI-generated identities become more common across […]

On Tuesday, Spotify announced plans to introduce "AI Persona" badges to certain artist profiles beginning mid-September. The move aims to provide listeners with greater clarity regarding the authenticity of artists they encounter, especially in cases where profiles may present AI-generated personas as human. Concerns have been raised about profiles that appear human but are in fact representations of AI-generated personas.

The AI Persona badges will be displayed across various areas of artist profiles, including banners, About sections, Search results, and track rows in playlists. Artists themselves can disclose through Spotify for Artists that their profile represents an AI Persona. Moreover, Spotify will conduct reviews of profiles that display photorealistic AI-generated imagery.

Profiles flagged by Spotify's review team will be notified and given the opportunity to self-disclose or appeal the decision. Listeners will also be able to determine whether an artist has transparently disclosed their AI Persona status or if Spotify has identified the profile through its own review process. It is important to note that the badge will be based solely on the artist's public identity and not on the manner in which the music was produced.

Written by urgent.news from The Indian Express's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at dailytimes.com.pk →

More in AI

New Tufts CSDD Analysis Finds AI Agents Can Deliver Up to $21 Million in Net Financial Value Per Drug Development Program and Up to 82x ROI

PALO ALTO, Calif. — Medable Inc., the leading technology platform for agentic clinical development, today announced a new Tufts Center for the Study of Drug Development (CSDD) analysis showing that an AI clinical monitoring agent can deliver net financial gains as high as $21 million per drug development program and 82 times the return on…

More from Wednesday 12 August →